ARTICLE | Analyst Picks & Changes
Analyst picks & changes
November 21, 1994 8:00 AM UTC
UBS Securities analyst Marc Ostro initiated coverage of Alpha-Beta Technology Inc. with a "buy." He said Betafectin, ABTI's Beta-glucan immunostimulant, has achieved the long-sought goal of an immune system stimulator without toxicity. ...